Click here for Mobile Site: http://m.cbs2chicago.com
  • Font Size    
E-mail

Close Window E-mail This Page

New Drug For Kidney Cancer Shows Promise

Required fields are marked with an asterisk(*)

The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +    Comments
Oct 5, 2009 6:09 pm US/Central

New Drug For Kidney Cancer Shows Promise

GAITHERSBURG, Md. (AP) ― Federal health advisers say an experimental kidney cancer drug from GlaxoSmithKline can benefit patients by slowing the disease, despite some risk of liver damage.

The Food and Drug Administration's cancer drug panel voted unanimously in favor of Glaxo's pazopanib pills for advanced kidney cancer, a rare but deadly form of the disease. The agency is not required to follow the group's advice, though it usually does.

Studies by the British drugmaker showed higher rates of liver damage among patients taking the drug, compared with patients taking a dummy pill. However, panelists said the risks were not significantly worse than those with similar cancer drugs.

(© 2010 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Add Comment

here. here. Need a log in? Register here
  •  * Will not be displayed with comment
  •  * e.g. (http://www.mywebsite.com)
  •  
  • Click here to refresh with new letters

Show Comments (0)

Close Window Login


Close Window Flag Comment


loading...

© MMX, CBS Broadcasting, Inc. All Rights Reserved.